Netherlands · Biotechnology startup
Netherlands · Alesta Therapeutics
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
Funding reportedLast round: Series A
What company datasets say Alesta Therapeutics raised
Funding, as reported
Reported in all67Min the source's currency
Last roundSeries A
Investors listed5
Founders and team
From Alesta Therapeutics's own website: 9 on the team.
On 3 portfolio pages
Investors who name them
Each firm lists Alesta Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Netherlands
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Alesta Therapeutics in front of investors. Or tell us what we have wrong.